OTCMKTS:RYMDF

Relay Medical Competitors

$0.25
0.00 (0.00 %)
(As of 05/10/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.23
$0.25
50-Day Range
$0.24
$0.52
52-Week Range
$0.13
$0.72
Volume59,211 shs
Average Volume143,087 shs
Market Capitalization$37.18 million
P/E RatioN/A
Dividend YieldN/A
Beta1.49

Competitors

Relay Medical (OTCMKTS:RYMDF) Vs. OCDX, OLK, NOTV, BDSX, AKU, and LHDX

Should you be buying RYMDF stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to Relay Medical, including Ortho Clinical Diagnostics (OCDX), Olink Holding AB (publ) (OLK), Inotiv (NOTV), Biodesix (BDSX), Akumin (AKU), and Lucira Health (LHDX).

Ortho Clinical Diagnostics (NASDAQ:OCDX) and Relay Medical (OTCMKTS:RYMDF) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Earnings and Valuation

This table compares Ortho Clinical Diagnostics and Relay Medical's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ortho Clinical DiagnosticsN/AN/AN/AN/AN/A
Relay MedicalN/AN/AN/AN/AN/A

Profitability

This table compares Ortho Clinical Diagnostics and Relay Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ortho Clinical DiagnosticsN/AN/AN/A
Relay MedicalN/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations for Ortho Clinical Diagnostics and Relay Medical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ortho Clinical Diagnostics011102.92
Relay Medical0000N/A

Ortho Clinical Diagnostics currently has a consensus price target of $24.5455, indicating a potential upside of 15.94%. Given Ortho Clinical Diagnostics' higher possible upside, research analysts plainly believe Ortho Clinical Diagnostics is more favorable than Relay Medical.

Summary

Ortho Clinical Diagnostics beats Relay Medical on 2 of the 2 factors compared between the two stocks.

Olink Holding AB (publ) (NASDAQ:OLK) and Relay Medical (OTCMKTS:RYMDF) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

Earnings & Valuation

This table compares Olink Holding AB (publ) and Relay Medical's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Olink Holding AB (publ)N/AN/AN/AN/AN/A
Relay MedicalN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations for Olink Holding AB (publ) and Relay Medical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Olink Holding AB (publ)02202.50
Relay Medical0000N/A

Olink Holding AB (publ) presently has a consensus target price of $44.00, suggesting a potential upside of 64.61%. Given Olink Holding AB (publ)'s higher probable upside, equities research analysts clearly believe Olink Holding AB (publ) is more favorable than Relay Medical.

Profitability

This table compares Olink Holding AB (publ) and Relay Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Olink Holding AB (publ)N/AN/AN/A
Relay MedicalN/AN/AN/A

Summary

Olink Holding AB (publ) beats Relay Medical on 2 of the 2 factors compared between the two stocks.

Relay Medical (OTCMKTS:RYMDF) and Inotiv (NASDAQ:NOTV) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, profitability and analyst recommendations.

Profitability

This table compares Relay Medical and Inotiv's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Relay MedicalN/AN/AN/A
InotivN/AN/AN/A

Valuation and Earnings

This table compares Relay Medical and Inotiv's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Relay MedicalN/AN/AN/AN/AN/A
InotivN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current recommendations and price targets for Relay Medical and Inotiv, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Relay Medical0000N/A
Inotiv0000N/A

Biodesix (NASDAQ:BDSX) and Relay Medical (OTCMKTS:RYMDF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

Analyst Ratings

This is a summary of recent recommendations and price targets for Biodesix and Relay Medical, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Biodesix00403.00
Relay Medical0000N/A

Biodesix currently has a consensus price target of $26.00, indicating a potential upside of 73.22%. Given Biodesix's higher possible upside, equities research analysts plainly believe Biodesix is more favorable than Relay Medical.

Valuation & Earnings

This table compares Biodesix and Relay Medical's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BiodesixN/AN/AN/AN/AN/A
Relay MedicalN/AN/AN/AN/AN/A

Profitability

This table compares Biodesix and Relay Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BiodesixN/AN/AN/A
Relay MedicalN/AN/AN/A

Summary

Biodesix beats Relay Medical on 2 of the 2 factors compared between the two stocks.

Akumin (NASDAQ:AKU) and Relay Medical (OTCMKTS:RYMDF) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, earnings, dividends, profitability and risk.

Profitability

This table compares Akumin and Relay Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AkuminN/AN/AN/A
Relay MedicalN/AN/AN/A

Valuation & Earnings

This table compares Akumin and Relay Medical's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AkuminN/AN/AN/AN/AN/A
Relay MedicalN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current recommendations and price targets for Akumin and Relay Medical, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Akumin00103.00
Relay Medical0000N/A

Insider and Institutional Ownership

30.4% of Akumin shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Akumin beats Relay Medical on 2 of the 2 factors compared between the two stocks.

Lucira Health (NASDAQ:LHDX) and Relay Medical (OTCMKTS:RYMDF) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation.

Profitability

This table compares Lucira Health and Relay Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Lucira HealthN/AN/AN/A
Relay MedicalN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Lucira Health and Relay Medical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Lucira Health11102.00
Relay Medical0000N/A

Lucira Health presently has a consensus price target of $9.00, suggesting a potential upside of 97.37%. Given Lucira Health's higher possible upside, research analysts plainly believe Lucira Health is more favorable than Relay Medical.

Earnings and Valuation

This table compares Lucira Health and Relay Medical's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lucira HealthN/AN/AN/AN/AN/A
Relay MedicalN/AN/AN/AN/AN/A

Summary

Lucira Health beats Relay Medical on 2 of the 2 factors compared between the two stocks.


Relay Medical Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ortho Clinical Diagnostics logo
OCDX
Ortho Clinical Diagnostics
1.7$21.17flat$4.71 billionN/A0.00
OLK
Olink Holding AB (publ)
1.2$26.73flat$3.18 billionN/A0.00
NOTV
Inotiv
0.3$28.71flat$408.43 millionN/A0.00Analyst Revision
Gap Up
Biodesix logo
BDSX
Biodesix
1.6$15.01flat$403.14 millionN/A0.00
Akumin logo
AKU
Akumin
0.6$3.06flat$217.73 millionN/A0.00
Lucira Health logo
LHDX
Lucira Health
1.0$4.56flat$175.72 millionN/A0.00Upcoming Earnings
Analyst Report
Analyst Revision
Global WholeHealth Partners logo
GWHP
Global WholeHealth Partners
0.0$0.49flat$38.34 millionN/A0.00
Epigenomics logo
EPGNY
Epigenomics
0.6$7.80flat$0.00N/A0.00
ETAH
Eternity Healthcare
0.6$0.00flat$0.00N/A0.00
MEDD
Medical Imaging
0.4$0.01flat$0.00N/A0.00News Coverage
Gap Down
Parallax Health Sciences logo
PRLX
Parallax Health Sciences
0.5$0.01flat$0.00N/A0.00
Siemens Healthineers logo
SMMNY
Siemens Healthineers
0.5$28.65flat$0.00N/A0.00Gap Down
WUXIF
WuXi AppTec
1.0$19.88flat$0.00N/A0.00
This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.